129 related articles for article (PubMed ID: 38616361)
21. Effect of extramedullary disease on allogeneic hematopoietic cell transplantation for pediatric acute myeloid leukemia: a nationwide retrospective study.
Sakaguchi H; Miyamura T; Tomizawa D; Taga T; Ishida H; Okamoto Y; Koh K; Yokosuka T; Yoshida N; Sato M; Noguchi M; Okada K; Hori T; Takeuchi M; Kosaka Y; Inoue M; Hashii Y; Atsuta Y
Bone Marrow Transplant; 2021 Aug; 56(8):1859-1865. PubMed ID: 33692532
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemia.
Hurley MY; Ghahramani GK; Frisch S; Armbrecht ES; Lind AC; Nguyen TT; Hassan A; Kreisel FH; Frater JL
Acta Derm Venereol; 2013 May; 93(3):319-24. PubMed ID: 23165700
[TBL] [Abstract][Full Text] [Related]
23. Organomegalies as a predictive indicator of leukemia cutis in patients with acute myeloid leukemia.
Kanitthamniyom C; Wannaphut C; Pattanaprichakul P; Kungwankiattichi S; Owattanapanich W
PLoS One; 2024; 19(2):e0297805. PubMed ID: 38363781
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features and prognosis of core binding factor acute myeloid leukemia children in South China: a multicenter study].
Guo BY; Wang Y; Li J; Li CF; Feng XQ; Zheng MC; Liu SX; Yang LH; Jiang H; Xu HG; He XL; Wen H
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):881-888. PubMed ID: 37803854
[No Abstract] [Full Text] [Related]
25. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
[TBL] [Abstract][Full Text] [Related]
26. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis.
Pina-Oviedo S; Torres-Cabala CA; Miranda RN; Tetzlaff MT; Singh S; Rapini RP; Prieto VG; Aung PP
Am J Dermatopathol; 2017 May; 39(5):388-392. PubMed ID: 27759701
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
[TBL] [Abstract][Full Text] [Related]
28. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
[TBL] [Abstract][Full Text] [Related]
29. Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
Støve HK; Sandahl JD; Abrahamsson J; Asdahl PH; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Hasle H
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28333413
[TBL] [Abstract][Full Text] [Related]
30. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.
Mathew RA; Bennett JM; Liu JJ; Komrokji RS; Lancet JE; Naghashpour M; Messina JL; List AF; Moscinski LC; Zhang L
Leuk Res; 2012 Jan; 36(1):72-80. PubMed ID: 21782240
[TBL] [Abstract][Full Text] [Related]
32. Ominous cutaneous presentation of acute myeloid leukemia without peripheral blood involvement upon initial presentation and relapse: case report and literature review.
Elkeeb D; Hopkins Z; Miles RR; Halwani A; Wada D
Eur J Dermatol; 2018 Dec; 28(6):809-817. PubMed ID: 30698150
[TBL] [Abstract][Full Text] [Related]
33. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
34. Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle?
Pramanik R; Tyagi A; Chopra A; Kumar A; Vishnubhatla S; Bakhshi S
Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e249-e254. PubMed ID: 29680411
[TBL] [Abstract][Full Text] [Related]
35. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
[TBL] [Abstract][Full Text] [Related]
36. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
[TBL] [Abstract][Full Text] [Related]
37. Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia.
Wang SY; Cheng WY; Mao YF; Zhu YM; Liu FJ; Ma TT; Shen Y
Hematol Oncol; 2019 Oct; 37(4):456-463. PubMed ID: 31348835
[TBL] [Abstract][Full Text] [Related]
38. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
[TBL] [Abstract][Full Text] [Related]
39. Blasts with folded nuclei: A histopathologic finding in myeloid leukemia cutis with NPM1 and FLT3 mutations.
Han S; Patel T; Garcia ML; Tirado M
J Cutan Pathol; 2024 Feb; 51(2):130-134. PubMed ID: 37866827
[TBL] [Abstract][Full Text] [Related]
40. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
